Neoforma.com, Inc. announced
Monday it may terminate its merger with Eclipsys Corp.
and HEALTHvision. - by Tiffany Kary, Inter@ctive Week
17 May 2000 - Neoforma's stock was hammered on March 30 when it
announced plans to buy Eclipsys for around US$1.45
billion and its affiliate HEALTHVision for around US$645
million. At that time, shares were down 33 percent to
Shares in the B2B marketplace for medical products
have been halved since then, closing at 9 5/32 on Monday.
Neoforma isn't alone; business-to-business companies
such as Purchase Pro and
VerticalNet have all suffered in the
In a separate release, healthcare computer services
company Eclipsys said the discussions include
whether the acquisition deal can be cancelled without
paying a termination fee.
Neoforma.com also said on Tuesday, that it is having
discussions about potential changes to the structure
and terms of its transactions with VHA and University
HealthSystem Consortium (UHC) the national
healthcare alliances that own Novation LLC.
Neoforma.com has an outsourcing agreement with
Novation, the supply company of VHA and UHC, to be
the exclusive provider of certain services that Novation
will offer to the healthcare organizations in its programs.
Neoforma said it won't release any details until definitive
agreements are reached.